U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204785
Company: XSPIRE PHARMA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TREZIX ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE 320.5MG;30MG;16MG CAPSULE;ORAL Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/26/2014 ORIG-1 Approval Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204785Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204785Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/15/2023 SUPPL-12 Labeling-Package Insert

Label is not available on this site.

12/15/2023 SUPPL-11 Labeling-Package Insert

Label is not available on this site.

03/04/2021 SUPPL-10 Labeling-Medication Guide, Labeling-Package Insert, Labeling-Patient Package Insert

Label is not available on this site.

10/11/2019 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

09/18/2018 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

01/29/2019 SUPPL-7 REMS - PROPOSAL - D-N-A

Label is not available on this site.

08/29/2017 SUPPL-5 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

02/07/2017 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

12/16/2016 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

12/16/2016 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/26/2014 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204785Orig1s000lbl.pdf
Back to Top